We are live on ! Find out more
PHGE.U

BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock

Delisted

PHGE.U was delisted on the 24th of October, 2024.

3 hedge funds and large institutions have $7K invested in BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more capital invested

Capital invested by funds: $6.84K → $7K (+$157)

0% more funds holding

Funds holding: 33 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
Holders Change %
0%
% of All Funds
0.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$13

Top Sellers

Rank Fund Capital Flow
1
CS
Clear Street
New York
-$400
2
Goldman Sachs
Goldman Sachs
New York
-$33
Name Holding Trade Value Shares
Change
Change in
Stake
Walleye Capital
1
Walleye Capital
New York
$4.44K
Goldman Sachs
2
Goldman Sachs
New York
$2.55K -$33 -10 -1%
UBS Group
3
UBS Group
Switzerland
$10 +$13 +4 New
CS
4
Clear Street
New York
-$400 -159 Closed

PHGE.U Hedge Fund Activity: Q1 2024 in Review

3 of the 6,945 institutional investors tracked by Wall St. Rank reported a position in BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock (PHGE.U) for Q1 2024, worth a combined $7K — up 2.3% from $6.84K a quarter earlier.

Fund positioning in PHGE.U was balanced in Q1 2024: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $13. The largest seller was Clear Street, exiting entirely with an estimated $400 sold.

  • 3 institutional investors held BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock (PHGE.U) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $7K of BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock stock for Q1 2024, up 2.3% quarter-over-quarter.
  • 1 fund opened new BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock positions in Q1 2024 and 1 closed out, a net change of 0 holders.
  • The largest BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock buyer in Q1 2024 was UBS Group, an estimated $13 added.
  • The largest BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock seller in Q1 2024 was Clear Street, an estimated $400 sold.

Based on aggregated 13F filings for Q1 2024.